1229 related articles for article (PubMed ID: 16630762)
1. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
2. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
3. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
4. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
[TBL] [Abstract][Full Text] [Related]
5. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
Ruigómez A; García Rodríguez LA; Panés J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
[TBL] [Abstract][Full Text] [Related]
6. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
9. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
[TBL] [Abstract][Full Text] [Related]
10. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
12. Fatigue in patients with primary sclerosing cholangitis.
Björnsson E; Simren M; Olsson R; Chapman RW
Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.
Simrén M; Axelsson J; Gillberg R; Abrahamsson H; Svedlund J; Björnsson ES
Am J Gastroenterol; 2002 Feb; 97(2):389-96. PubMed ID: 11866278
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
Jones MP; Bratten J; Keefer L
Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity in irritable bowel syndrome.
Whitehead WE; Palsson OS; Levy RR; Feld AD; Turner M; Von Korff M
Am J Gastroenterol; 2007 Dec; 102(12):2767-76. PubMed ID: 17900326
[TBL] [Abstract][Full Text] [Related]
16. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.
Jones MP; Wessinger S; Crowell MD
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):474-81. PubMed ID: 16616353
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms.
Kalaitzakis E; Carlsson E; Josefsson A; Bosaeus I
Scand J Gastroenterol; 2008; 43(9):1057-65. PubMed ID: 18609190
[TBL] [Abstract][Full Text] [Related]
18. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
[TBL] [Abstract][Full Text] [Related]
19. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
[TBL] [Abstract][Full Text] [Related]
20. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
